FFA
IONS icon

Farther Finance Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Farther Finance Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141K Buy
1,883
+684
+57% +$54K ﹤0.01% 2266
2025
Q4 		$94.9K Buy
1,199
+633
+112% +$47.7K ﹤0.01% 2378
2025
Q3 		$37K Buy
566
+133
+31% +$6.49K ﹤0.01% 2629
2025
Q2 		$17.1K Sell
433
-39
-8% -$1.28K ﹤0.01% 2778
2025
Q1 		$12.9K Sell
472
-179
-27% -$5.86K ﹤0.01% 2611
2024
Q4 		$22.8K Buy
651
+30
+5% +$1.12K ﹤0.01% 2031
2024
Q3 		$24.9K Buy
621
+58
+10% +$2.7K ﹤0.01% 1981
2024
Q2 		$26.5K Sell
563
-6
-1% -$246 ﹤0.01% 1671
2024
Q1 		$25K Hold
569
– – ﹤0.01% 1422
2023
Q4 		$28.8K Buy
569
+329
+137% +$15.8K ﹤0.01% 1224
2023
Q3 		$10.9K Sell
240
-7
-3% -$289 ﹤0.01% 1264
2023
Q2 		$10.1K Buy
247
+91
+58% +$3.5K ﹤0.01% 1189
2023
Q1 		$5.58K Sell
156
-3
-2% -$113 ﹤0.01% 1308
2022
Q4 		$6K Buy
+159
New +$6.69K ﹤0.01% 1106

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Farther Finance Advisors's IONS Position: Q1 2026 in Review

Farther Finance Advisors increased its Ionis Pharmaceuticals (IONS) stake by 57% in Q1 2026, buying an estimated $54K and bringing the position to 1,883 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

Farther Finance Advisors first reported a position in IONS in Q4 2022 and has held it in 14 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Farther Finance Advisors held 1,883 shares of Ionis Pharmaceuticals worth $141K as of Q1 2026.
  • Farther Finance Advisors bought 684 Ionis Pharmaceuticals shares in Q1 2026, an estimated $54K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q1 2026, its #2266 holding.
  • Farther Finance Advisors first reported a position in Ionis Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.